Ignite Creation Date:
2024-05-06 @ 2:07 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04224688
Status:
TERMINATED
Last Update Posted:
2023-08-08
First Post:
2020-01-08
Brief Title:
A Study to Assess the Efficacy Safety and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia ITP
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma